Make your products visible globally with Elite Membership.
I agree to the terms and conditions
Existing User?
Sign In with Email
Remember Me Forgot Password?
New User?
Enter your registered Email ID to get reset password.
Elite Member
Individual Register
The drug Retavase is used to treat acute ST-elevation myocardial infarction (STEMI).
Is manufacturing enough or does incorporating good manufacturing practices give an additional edge?
The transaction is expected to close during Q4 2017, before which a new trade name will be selected and announced for the business.
Supports fast growing generic pharmaceutical manufacturing market in South Asia.
Additional capacity expansion of ibuprofen plant in Bishop, Texas; Strengthening position in the ibuprofen market.
Data shows a specific, adaptive immune pattern triggered by NBTXR3 treatment
Accelerates development timelines with faster, easier selection and scale up of clones
Building a global trusted generics company
The choice of products/ medicines will be shifted from doctors to chemists, not patients
Allergopharma invests €42 million in the project, for manufacturing causal treatment products